{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:14Z","timestamp":1786997894663,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.09.024","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T08:01:05Z","timestamp":1505808065000},"page":"5814-5818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine"],"prefix":"10.1016","volume":"35","author":[{"given":"Sema","family":"Mandal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.024_b0005","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.09.024_b0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/archdischild-2015-308928","article-title":"Enter B and W: two new meningococcal vaccine programmes launched","volume":"101","author":"Ladhani","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2017.09.024_b0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in england and wales","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.024_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES2015.20.28.21188","article-title":"Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015","volume":"20","author":"Campbell","year":"2015","journal-title":"EuroSurveill"},{"key":"10.1016\/j.vaccine.2017.09.024_b0025","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","article-title":"Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the meningococcal reference unit","volume":"55","author":"Gray","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2017.09.024_b0030","unstructured":"Office for National Statistics. Mid-year Population Estimates explorable datasets 2016. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/datasets\/midyearpopulationestimatesexplorabledatasets [accessed November 02, 2016]."},{"key":"10.1016\/j.vaccine.2017.09.024_b0035","unstructured":"Office for National Statistics. Annual mid-year population estimates: 2014; 2015. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/annualmidyearpopulationestimates\/2015-06-25 (accessed January 04, 2017)."},{"key":"10.1016\/j.vaccine.2017.09.024_b0040","unstructured":"Public Health England. MenACWY schools-based programme coverage estimates, report: to end of August 2016. Heal Prot Rep 2016;10."},{"key":"10.1016\/j.vaccine.2017.09.024_b0045","unstructured":"Public Health England. MenACWY vaccine coverage estimates, report: to end of July 2016. Heal Prot Rep 2016."},{"issue":"7","key":"10.1016\/j.vaccine.2017.09.024_b0050","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3201\/eid2307.170236","article-title":"Emergency meningococcal ACWY vaccination program for teenagers to control group W Meningococcal Disease, England, 2015\u20132016","volume":"23","author":"Campbell","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.024_b0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S0950268899002368","article-title":"Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation","volume":"122","author":"Neal","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.09.024_b0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S0950268801005301","article-title":"Risk factors for meningococcal disease in university halls of residence","volume":"126","author":"Nelson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.09.024_b0065","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.286.6.688","article-title":"Risk factors for meningococcal disease in college students","volume":"286","author":"Bruce","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.09.024_b0070","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0140-6736(14)60842-4","article-title":"Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial","volume":"384","author":"Read","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.09.024_b0075","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.024_b0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12879-015-1247-7","article-title":"Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources","volume":"15","author":"Ladhani","year":"2015","journal-title":"BMC Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T08:48:21Z","timestamp":1531558101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17312410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":16,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17312410"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of invasive meningococcal disease in university students in England and optimal strategies for protection using MenACWY vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}